By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fluidigm has paid Life Technologies $2 million to shield itself from litigation related to Life Tech's PCR patents, some of which were the subject of lawsuits the two firms filed against each other in June.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.